Cargando…
A mixed method study design to explore the adherence of haematological cancer patients to oral anticancer medication in a multilingual and multicultural outpatient setting: The MADESIO protocol
BACKGROUND: Patients with haematologic malignancies are increasingly treated by oral anticancer medications, heightening the challenge of ensuring optimal adherence to treatment. However, except for chronic myelogenous leukaemia or acute lymphoid leukaemia, the extent of non-adherence has rarely bee...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224871/ https://www.ncbi.nlm.nih.gov/pubmed/34166438 http://dx.doi.org/10.1371/journal.pone.0253526 |
_version_ | 1783711972186914816 |
---|---|
author | Michiels, Sandra Tricas-Sauras, Sandra Dauvrin, Marie Bron, Dominique Kirakoya-Samadoulougou, Fati |
author_facet | Michiels, Sandra Tricas-Sauras, Sandra Dauvrin, Marie Bron, Dominique Kirakoya-Samadoulougou, Fati |
author_sort | Michiels, Sandra |
collection | PubMed |
description | BACKGROUND: Patients with haematologic malignancies are increasingly treated by oral anticancer medications, heightening the challenge of ensuring optimal adherence to treatment. However, except for chronic myelogenous leukaemia or acute lymphoid leukaemia, the extent of non-adherence has rarely been investigated in outpatient settings, particularly for migrant population. With growing numbers of migrants in Belgium, identifying potential differences in drug use is essential. Also, previous research regarding social determinants of health highlight important disparities for migrant population. Difficulties in communication between health caregivers and patients from different cultural and ethnic backgrounds has been underlined. METHODS: Using a sequential mixed method design, the MADESIO protocol explores the adherence to oral anticancer medications in patients with haematological malignancies and among first and second generation migrants of varied origin. Conducted in the ambulatory setting, a first quantitative strand will measure adherence rates and associated risk factors in two sub-groups of patients with haematological malignancies (group A: first and second generation migrants and group B: non-migrants). The second qualitative strand of this study uses semi-structured interviews to address address the patients’ subjective meanings and understand the statistical associations observed in the quantitative study (strand one). MADESIO aims to provide a first assessment of whether and why migrants constitute a population at risk concerning adherence to oral anticancer medications. DISCUSSION: Our protocol is designed to provide a comprehensive understanding of adherence in a specific population. The methodological choices applied allow to explore adherence among patients from diverse linguistic and cultural backgrounds. A particular emphasis has been paid to minimize the biases and increase the reliability of the data collected. Easily reproductible, the MADESIO design may help healthcare services to screen adherence to Oral anticancer medications and to guide providers in choosing the best strategies to address medication adherence of migrants or minority diverse population. |
format | Online Article Text |
id | pubmed-8224871 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-82248712021-07-19 A mixed method study design to explore the adherence of haematological cancer patients to oral anticancer medication in a multilingual and multicultural outpatient setting: The MADESIO protocol Michiels, Sandra Tricas-Sauras, Sandra Dauvrin, Marie Bron, Dominique Kirakoya-Samadoulougou, Fati PLoS One Study Protocol BACKGROUND: Patients with haematologic malignancies are increasingly treated by oral anticancer medications, heightening the challenge of ensuring optimal adherence to treatment. However, except for chronic myelogenous leukaemia or acute lymphoid leukaemia, the extent of non-adherence has rarely been investigated in outpatient settings, particularly for migrant population. With growing numbers of migrants in Belgium, identifying potential differences in drug use is essential. Also, previous research regarding social determinants of health highlight important disparities for migrant population. Difficulties in communication between health caregivers and patients from different cultural and ethnic backgrounds has been underlined. METHODS: Using a sequential mixed method design, the MADESIO protocol explores the adherence to oral anticancer medications in patients with haematological malignancies and among first and second generation migrants of varied origin. Conducted in the ambulatory setting, a first quantitative strand will measure adherence rates and associated risk factors in two sub-groups of patients with haematological malignancies (group A: first and second generation migrants and group B: non-migrants). The second qualitative strand of this study uses semi-structured interviews to address address the patients’ subjective meanings and understand the statistical associations observed in the quantitative study (strand one). MADESIO aims to provide a first assessment of whether and why migrants constitute a population at risk concerning adherence to oral anticancer medications. DISCUSSION: Our protocol is designed to provide a comprehensive understanding of adherence in a specific population. The methodological choices applied allow to explore adherence among patients from diverse linguistic and cultural backgrounds. A particular emphasis has been paid to minimize the biases and increase the reliability of the data collected. Easily reproductible, the MADESIO design may help healthcare services to screen adherence to Oral anticancer medications and to guide providers in choosing the best strategies to address medication adherence of migrants or minority diverse population. Public Library of Science 2021-06-24 /pmc/articles/PMC8224871/ /pubmed/34166438 http://dx.doi.org/10.1371/journal.pone.0253526 Text en © 2021 Michiels et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Study Protocol Michiels, Sandra Tricas-Sauras, Sandra Dauvrin, Marie Bron, Dominique Kirakoya-Samadoulougou, Fati A mixed method study design to explore the adherence of haematological cancer patients to oral anticancer medication in a multilingual and multicultural outpatient setting: The MADESIO protocol |
title | A mixed method study design to explore the adherence of haematological cancer patients to oral anticancer medication in a multilingual and multicultural outpatient setting: The MADESIO protocol |
title_full | A mixed method study design to explore the adherence of haematological cancer patients to oral anticancer medication in a multilingual and multicultural outpatient setting: The MADESIO protocol |
title_fullStr | A mixed method study design to explore the adherence of haematological cancer patients to oral anticancer medication in a multilingual and multicultural outpatient setting: The MADESIO protocol |
title_full_unstemmed | A mixed method study design to explore the adherence of haematological cancer patients to oral anticancer medication in a multilingual and multicultural outpatient setting: The MADESIO protocol |
title_short | A mixed method study design to explore the adherence of haematological cancer patients to oral anticancer medication in a multilingual and multicultural outpatient setting: The MADESIO protocol |
title_sort | mixed method study design to explore the adherence of haematological cancer patients to oral anticancer medication in a multilingual and multicultural outpatient setting: the madesio protocol |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224871/ https://www.ncbi.nlm.nih.gov/pubmed/34166438 http://dx.doi.org/10.1371/journal.pone.0253526 |
work_keys_str_mv | AT michielssandra amixedmethodstudydesigntoexploretheadherenceofhaematologicalcancerpatientstooralanticancermedicationinamultilingualandmulticulturaloutpatientsettingthemadesioprotocol AT tricassaurassandra amixedmethodstudydesigntoexploretheadherenceofhaematologicalcancerpatientstooralanticancermedicationinamultilingualandmulticulturaloutpatientsettingthemadesioprotocol AT dauvrinmarie amixedmethodstudydesigntoexploretheadherenceofhaematologicalcancerpatientstooralanticancermedicationinamultilingualandmulticulturaloutpatientsettingthemadesioprotocol AT brondominique amixedmethodstudydesigntoexploretheadherenceofhaematologicalcancerpatientstooralanticancermedicationinamultilingualandmulticulturaloutpatientsettingthemadesioprotocol AT kirakoyasamadoulougoufati amixedmethodstudydesigntoexploretheadherenceofhaematologicalcancerpatientstooralanticancermedicationinamultilingualandmulticulturaloutpatientsettingthemadesioprotocol AT michielssandra mixedmethodstudydesigntoexploretheadherenceofhaematologicalcancerpatientstooralanticancermedicationinamultilingualandmulticulturaloutpatientsettingthemadesioprotocol AT tricassaurassandra mixedmethodstudydesigntoexploretheadherenceofhaematologicalcancerpatientstooralanticancermedicationinamultilingualandmulticulturaloutpatientsettingthemadesioprotocol AT dauvrinmarie mixedmethodstudydesigntoexploretheadherenceofhaematologicalcancerpatientstooralanticancermedicationinamultilingualandmulticulturaloutpatientsettingthemadesioprotocol AT brondominique mixedmethodstudydesigntoexploretheadherenceofhaematologicalcancerpatientstooralanticancermedicationinamultilingualandmulticulturaloutpatientsettingthemadesioprotocol AT kirakoyasamadoulougoufati mixedmethodstudydesigntoexploretheadherenceofhaematologicalcancerpatientstooralanticancermedicationinamultilingualandmulticulturaloutpatientsettingthemadesioprotocol |